Health Tech Capitol | Newsroom
15131
paged,page-template,page-template-blog-masonry,page-template-blog-masonry-php,page,page-id-15131,paged-43,page-paged-43,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Newsroom

Cellectar Biosciences Inc., a Madison developer of cancer treatment and diagnostic drugs, said Wednesday it has received $2 million from the National Cancer Institute...